alexa Is The Current Analysis Of MAHs Of Off-label Use Constructive? | 68898
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

9th International Conference and Exhibition on Pharmacovigilance & Drug Safety

Anika Staack
MEDICE, Germany
Keynote: J Pharmacovigil
DOI: 10.4172/2329-6887-C1-025
Abstract
Statement of the Problem: Off-label use is the intentional use of a drug outside the authorized product information. Within the European Union, a recent study revealed that a majority of published studies reporting levels of 20% or higher for the use of off-label medication and more than 55% when looking at the percentage of doctors prescribing off-label. Off-label use might be done due to unavailable authorized products for a specific age group (e.g. off label use in children) or therapeutic groups (e.g. anti-bacterial agents). In the latter, this has an impact on general public health in case of increase in resistance. Off-label use has to be collected by MAHs for further assessment and evaluation. Normally the MAH receives information about off-label use when additional adverse drug reactions happened or via medical enquiries by the treating physicians. The MAHs inform then the reporting physician about the off-label use. Normally, no further data are directly provided by the physician leading to an under-reporting of off-label use and therefore, a lack of appropriate analyzing possibilities and corrective action-taking. Methodology & Theoretical Orientation: In the European database of adverse drug reaction reports the total number of reported cases and the number of reported off-label use was analysed for seven antibiotics. The data include all reports up to March 2017. Based on feedback from physicians via interviews, nearly 50% prescribed antibiotics off-label. Conclusion & Significance: There is an under-reporting of off-label use in regards to what physicians are reporting on interviews and reporting as cases. This is leading to data of poor quality and evaluability. The analysis process of off-label use should therefore be adopted to reflect the current situation which might lead to a better use of knowledge and current treatment methods of physicians.
Biography

Anika Staack studied Biology at the University of Marburg (Master degree). She started working as Clinical Research Associate for cancer studies for 1.5 years and switched then into the field of drug safety. For more than 14 years she is working in the area of drug safety/pharmacovigilance and people management. Main areas of research interest are the impact of change in the pharmacovigilance legislation and its influence on quality as well as training. Currently she is working as EU-QPPV for a pharmaceutical company. Further education includes certified business trainer and meditation therapist.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7